vs
Capri Holdings Ltd（CPRI）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Capri Holdings Ltd的季度营收约是Royalty Pharma plc的1.6倍（$1.0B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 11.3%，领先23.1%），Royalty Pharma plc同比增速更快（4.8% vs -18.7%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -15.2%）
卡普里控股是一家跨国时尚集团，注册于英属维尔京群岛，行政总部位于伦敦，运营办公室设在纽约。品牌由美国设计师迈克尔·高仕于1981年创立，主营服饰、鞋履、手表、手袋及其他配饰产品，截至2015年在全球拥有550余家门店，以及超过1500个店中店专柜。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CPRI vs RPRX — 直观对比
营收规模更大
CPRI
是对方的1.6倍
$622.0M
营收增速更快
RPRX
高出23.5%
-18.7%
净利率更高
RPRX
高出23.1%
11.3%
两年增速更快
RPRX
近两年复合增速
-15.2%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $622.0M |
| 净利润 | $116.0M | $214.2M |
| 毛利率 | 60.8% | — |
| 营业利润率 | 4.5% | 62.4% |
| 净利率 | 11.3% | 34.4% |
| 营收同比 | -18.7% | 4.8% |
| 净利润同比 | 121.2% | 2.9% |
| 每股收益（稀释后） | $0.96 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPRIRPRX
| Q4 25 | $1.0B | $622.0M | ||
| Q3 25 | $856.0M | $609.3M | ||
| Q2 25 | $797.0M | $578.7M | ||
| Q1 25 | $1.6B | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $878.0M | $564.7M | ||
| Q2 24 | $848.0M | $537.3M | ||
| Q1 24 | — | $568.0M |
净利润CPRIRPRX
| Q4 25 | $116.0M | $214.2M | ||
| Q3 25 | $-28.0M | $288.2M | ||
| Q2 25 | $53.0M | $30.2M | ||
| Q1 25 | $-645.0M | $238.3M | ||
| Q4 24 | $-547.0M | $208.2M | ||
| Q3 24 | $24.0M | $544.0M | ||
| Q2 24 | $-14.0M | $102.0M | ||
| Q1 24 | — | $4.8M |
毛利率CPRIRPRX
| Q4 25 | 60.8% | — | ||
| Q3 25 | 61.0% | — | ||
| Q2 25 | 63.0% | — | ||
| Q1 25 | 64.9% | — | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | 62.3% | — | ||
| Q2 24 | 63.1% | — | ||
| Q1 24 | — | — |
营业利润率CPRIRPRX
| Q4 25 | 4.5% | 62.4% | ||
| Q3 25 | -1.4% | 70.1% | ||
| Q2 25 | 2.0% | 36.3% | ||
| Q1 25 | -47.5% | 94.0% | ||
| Q4 24 | 2.4% | 60.9% | ||
| Q3 24 | -0.7% | — | ||
| Q2 24 | 1.3% | 50.2% | ||
| Q1 24 | — | -13.0% |
净利率CPRIRPRX
| Q4 25 | 11.3% | 34.4% | ||
| Q3 25 | -3.3% | 47.3% | ||
| Q2 25 | 6.6% | 5.2% | ||
| Q1 25 | -39.1% | 41.9% | ||
| Q4 24 | -51.2% | 35.1% | ||
| Q3 24 | 2.7% | 96.3% | ||
| Q2 24 | -1.7% | 19.0% | ||
| Q1 24 | — | 0.8% |
每股收益（稀释后）CPRIRPRX
| Q4 25 | $0.96 | $0.49 | ||
| Q3 25 | $-0.22 | $0.67 | ||
| Q2 25 | $0.44 | $0.07 | ||
| Q1 25 | $-5.47 | $0.55 | ||
| Q4 24 | $-4.61 | $0.46 | ||
| Q3 24 | $0.20 | $1.21 | ||
| Q2 24 | $-0.12 | $0.23 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $154.0M | $618.7M |
| 总债务越低越好 | $234.0M | $9.0B |
| 股东权益账面价值 | $105.0M | $9.7B |
| 总资产 | $3.3B | $19.6B |
| 负债/权益比越低杠杆越低 | 2.23× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CPRIRPRX
| Q4 25 | $154.0M | $618.7M | ||
| Q3 25 | $120.0M | $938.9M | ||
| Q2 25 | $129.0M | $631.9M | ||
| Q1 25 | $107.0M | $1.1B | ||
| Q4 24 | $356.0M | $929.0M | ||
| Q3 24 | $182.0M | $950.1M | ||
| Q2 24 | $213.0M | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务CPRIRPRX
| Q4 25 | $234.0M | $9.0B | ||
| Q3 25 | $1.8B | $8.9B | ||
| Q2 25 | $1.7B | $8.0B | ||
| Q1 25 | $1.5B | $7.6B | ||
| Q4 24 | $1.5B | $7.6B | ||
| Q3 24 | $1.7B | $7.6B | ||
| Q2 24 | $1.7B | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益CPRIRPRX
| Q4 25 | $105.0M | $9.7B | ||
| Q3 25 | $-74.0M | $9.6B | ||
| Q2 25 | $-17.0M | $9.5B | ||
| Q1 25 | $368.0M | $9.8B | ||
| Q4 24 | $1.1B | $10.3B | ||
| Q3 24 | $1.5B | $10.3B | ||
| Q2 24 | $1.6B | $9.8B | ||
| Q1 24 | — | $9.9B |
总资产CPRIRPRX
| Q4 25 | $3.3B | $19.6B | ||
| Q3 25 | $5.6B | $19.3B | ||
| Q2 25 | $5.5B | $18.3B | ||
| Q1 25 | $5.2B | $17.6B | ||
| Q4 24 | $5.9B | $18.2B | ||
| Q3 24 | $6.8B | $18.0B | ||
| Q2 24 | $6.6B | $17.7B | ||
| Q1 24 | — | $16.1B |
负债/权益比CPRIRPRX
| Q4 25 | 2.23× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | 4.05× | 0.78× | ||
| Q4 24 | 1.38× | 0.74× | ||
| Q3 24 | 1.15× | 0.74× | ||
| Q2 24 | 1.08× | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $202.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $183.0M | — |
| 自由现金流率自由现金流/营收 | 17.9% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | 1.74× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-134.0M | — |
8季度趋势，按日历期对齐
经营现金流CPRIRPRX
| Q4 25 | $202.0M | $827.1M | ||
| Q3 25 | $-52.0M | $702.6M | ||
| Q2 25 | $-8.0M | $364.0M | ||
| Q1 25 | $-161.0M | $596.1M | ||
| Q4 24 | $309.0M | $742.5M | ||
| Q3 24 | $50.0M | $703.6M | ||
| Q2 24 | $83.0M | $658.2M | ||
| Q1 24 | — | $664.6M |
自由现金流CPRIRPRX
| Q4 25 | $183.0M | — | ||
| Q3 25 | $-65.0M | — | ||
| Q2 25 | $-21.0M | — | ||
| Q1 25 | $-231.0M | — | ||
| Q4 24 | $287.0M | — | ||
| Q3 24 | $30.0M | — | ||
| Q2 24 | $67.0M | — | ||
| Q1 24 | — | — |
自由现金流率CPRIRPRX
| Q4 25 | 17.9% | — | ||
| Q3 25 | -7.6% | — | ||
| Q2 25 | -2.6% | — | ||
| Q1 25 | -14.0% | — | ||
| Q4 24 | 26.9% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 7.9% | — | ||
| Q1 24 | — | — |
资本支出强度CPRIRPRX
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | — | — |
现金转化率CPRIRPRX
| Q4 25 | 1.74× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | -0.15× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | 2.08× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPRI
| Michael Kors Segment | $593.0M | 58% |
| Other | $379.0M | 37% |
| Jimmy Choo Segment | $53.0M | 5% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
